NC-SYNTERACT
Synteract , an innovative CRO partnering with biotech and pharma companies to bring new medicines to market, has hired two experienced leaders to further strengthen its Centers of Development in Oncology and Rare/Orphan diseases. Given the enhanced strategic solutions that often result from the intersecting expertise of Synteract’s centers of development, clients will derive further benefit from the therapeutic knowledge and clinical development acumen gained from these key additions.
Hassan Aly, M.D., Ph.D., has joined Synteract as senior medical director supporting Synteract’s Oncology Center of Development and Derek Ansel has joined as director of Rare and Orphan Disease Development . Both are clinical strategists with multidisciplinary experience in developing and operationalizing global therapeutic strategies.
“Rare disease, oncology, and hematology clinical trials pose unique challenges that require the ability to think broadly while applying very specific trial strategies,” said Steve Powell, Synteract CEO . “Both Hassan and Derek bring a wealth of knowledge, expertise, and creativity, coupled with a passion to help patients and families, that will help us to further advance trials in the most complex and acute areas of need.”
Dr. Aly is a certified hematologist with over 20 years’ experience in oncology/hematology medical research and patient treatment, including nine plus years in the clinical research and pharmaceutical industry. He brings deep therapeutic expertise across all phases of oncology/hematology drug development, having consulted on complex study design, conduct, monitoring, and submission. Prior to joining Synteract, he worked at AstraZeneca, Boehringer-Ingelheim, and leading CRO’s.
In addition, Dr. Aly has authored or co-authored 105 papers on the treatment and biology of malignant hematological diseases in peer-reviewed medical periodicals and made more than 70 presentations at British and European conferences.
Prior to joining Synteract, Derek Ansel was a clinical strategy lead at the Center for Rare Diseases and a co-founder of the Gene Therapy Working Group at a leading CRO. Ansel has a breadth of clinical research experience spanning from the laboratory through clinical monitoring and project management, across Phases I-IV. He will work in a multidisciplinary, cross therapeutic team, where he will apply extensive gene and cell therapy expertise developed from his work in several liver-targeted gene therapy programs.
Ansel frequently speaks at industry events. He is a member of the ACRP and holds a Certified Clinical Research Associate (CCRA) credential. He is an IRB member at the Thomas Jefferson University in Philadelphia and is also a contributing member of Cochrane, a non-profit organization that promotes evidence-based decision making in healthcare.
Dr. Frank Santoro , chief medical officer for Synteract, commented, “Hassan and Derek bring unique skillsets to our centers of development with a combination of medical, therapeutic, and operational know-how related to running complex trials. This expertise, along with their crossover experience in multiple therapeutic areas, offers exceptional insight to our clients looking to partner with Synteract for their clinical development needs.”
About Synteract
“Bringing Clinical Trials to Life” represents Synteract’s commitment to engage with drug developers, patients, investigators, and regulatory experts to bring insights to action and make better therapies a reality. Synteract supports biotech and pharma companies across all phases of drug development to help bring new medicines to market. Synteract has conducted nearly 4,000 studies on six continents and in more than 60 countries. It has contributed to more than 240 product approvals. Synteract offers notable depth of therapeutic expertise in oncology, dermatology, general medicine, neuroscience, pediatrics, and rare and orphan diseases. Connect on LinkedIn and Twitter .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190925005206/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wolters Kluwer survey reveals key drivers of job satisfaction among Dutch accounting professionals6.8.2025 08:00:00 CEST | Press release
Findings highlight the importance of workplace atmosphere, meaningful work, and automation in boosting employee happiness and retention Wolters Kluwer Tax & Accounting Netherlands today released the results of its latest survey, “Work Pressure or Job Satisfaction?”, offering a revealing look into what drives happiness—and frustration—among accounting professionals in the Netherlands. The survey, conducted in May 2025, gathered insights from professionals across a range of roles and firm sizes, providing a snapshot of the sector’s evolving expectations and challenges. “The future of the accounting profession calls for greater focus on employee well-being and educational innovation,” said Jeffrey Smit, Vice President & General Manager, Wolters Kluwer Tax & Accounting, Europe Region West. “True gains come from sustainable employability, future-focused expertise, and job satisfaction. Today’s accountant is no longer just a number-cruncher, but a savvy advisor who brings together data, tech
The GTDC, CONTEXT and IDC Forge Unprecedented Global Alliance to Deliver Technology Sales Data6.8.2025 04:00:00 CEST | Press release
First-of-its-kind collaboration will result in like-for-like, actionable data for IT vendors and distributors across Asia Pacific, North America, Europe, and the Middle East markets Three powerhouse leaders in the global distribution and data intelligence sector are partnering to create the first and only data source that will deliver comprehensive sell-through insights across Asia Pacific, North America, Europe, and the Middle East. The collaboration will deliver the definitive global source of technology sales-through data across key markets, providing vendors and distributors with an unparalleled 360-degree view of market trends. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250805421998/en/ IDC, GTDC and CONTEXT, powerhouse leaders in the global distribution and data intelligence sector, are partnering to create the first and only data source that will deliver comprehensive sell-through insights across Asia Pacific, Nor
The Hackett Group® and Celonis Partner to Accelerate ROI With Unmatched AI + Process Intelligence Solutions5.8.2025 23:18:00 CEST | Press release
The Hackett Group, Inc. (NASDAQ: HCKT), a leading generative artificial intelligence (Gen AI) consultancy and executive advisory firm, today announced a collaboration with Celonis, a global leader in process mining, to deliver intelligent enterprise automation that drives measurable business results at unprecedented speed. Using Celonis process intelligence and The Hackett Group’s AI XPLR™ and ZBrain™ platforms – that leverage The Hackett Group’s globally recognized enterprise benchmarking and business transformation IP – companies can compare their performance against Digital World Class® performance standards. This will allow clients to quickly identify the greatest ROI opportunities and harness unmatched process intelligence and agentic workflow solutions to achieve their value realization objectives. The partnership delivers: Clarity on the right tech investments: Combining The Hackett Group’s industry benchmarks with Celonis process intelligence and its own benchmarks on leading m
IFF Reports Second Quarter 2025 Results5.8.2025 22:26:00 CEST | Press release
Reaffirms Full Year 2025 Financial GuidanceLeverage Reduced to 2.5x; Announces new $500M Share Repurchase AuthorizationEnters into Definitive Agreement to Sell Soy Crush, Concentrates & Lecithin Business; Evaluating Strategic Alternatives for Food Ingredients Segment IFF (NYSE: IFF) reported financial results for the second quarter ended June 30, 2025. Management Commentary “IFF’s second-quarter results reflect the progress we are making to strengthen our business and advance our strategic agenda,” said Erik Fyrwald, CEO of IFF. “Our teams delivered top-line growth and improved profitability, driven by disciplined execution and a strong focus on productivity. We also made strides in reshaping our portfolio by closing the divestitures of Pharma Solutions and Nitrocellulose, and successfully completing our debt tender offering - reducing leverage to 2.5x, ahead of our target and reinforcing our financial position.” “Additionally, we announced the expected divestiture of our soy crush, co
Cooler Master’s MasterHUB Wins Red Dot Award for Design Excellence5.8.2025 21:36:00 CEST | Press release
Modular Control Deck Honored in 2025 Brands & Communication Category Cooler Master, a global leader in innovative thermal solutions and PC hardware, today announced that MasterHUB has won the Red Dot Award in the 2025 Brands & Communication Design category. The Red Dot is an internationally recognized symbol of outstanding design quality, awarded by a jury of global design experts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250805404259/en/ Cooler Master's Award-Winning MasterHUB Stream Deck. This recognition highlights Cooler Master’s FreeForm 2.0 design philosophy, which empowers users to build personalized, modular systems that evolve with their needs. MasterHUB embodies this approach by offering a flexible foundation for streamers, editors, and creatives to shape their own workflows. “MasterHUB was designed to grow with you,” said Matteo Stracciari, General Manager at Cooler Master. “Whether you're mixing audio, edit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom